SeaStar Medical Holding Corp 8-K

What Happened

• SeaStar Medical Holding Corp. announced retention bonuses approved by its Compensation Committee in late June 2026 for two senior executives: Eric Schlorff and Kevin Chung. The Committee approved the awards on June 25, 2026 and the company entered into Retention Bonus Program Agreements on June 29, 2026.
• The bonuses vest and are payable in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, subject to the executives’ continued employment through each vesting date. The agreements were filed as Exhibits 10.1 and 10.2 to the 8-K.

Key Details

• Total retention amounts: Eric Schlorff $200,000; Kevin Chung $140,000.
• Each 1/3 cash installment: Schlorff $66,666; Chung $46,666.
• In addition to cash, each installment includes an extra 25% of the payment delivered in the company’s common stock under the 2022 Omnibus Incentive Plan; shares issued are based on the closing share price on each vesting date. (Per-1/3 restricted stock value listed as $16,666.50 for Schlorff and $11,666.50 for Chung.)
• If an executive leaves before a vesting date, no further payments are made; if separated without cause, the executive receives a pro‑rata amount for the then-current upcoming payment. The program is part of a broader retention effort for long‑serving employees.

Why It Matters

• These arrangements are aimed at retaining key management through early 2027. For investors, the direct cash cost is modest (combined $340,000), but the equity component dilutes shareholders slightly depending on share-price‑based issuance.
• The filing signals management and the board are prioritizing continuity of leadership—relevant if you consider company strategy execution and near‑term operational stability.